Hemab Therapeutics Holdings, Inc. Common Stock (COAG) — Financial Flexibility Index
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) has a Financial Flexibility Index of -0.17x as of December 2025. Free cash flow of $-61.46 Million (operating CF $-61.48 Million minus capex $16.00K) represents 0% of total liabilities ($371.42 Million). Check Hemab Therapeutics Holdings, Inc. Common (COAG) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hemab Therapeutics Holdings, Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Hemab Therapeutics Holdings, Inc. Common Stock across 2 annual periods. See working capital position of Hemab Therapeutics Holdings, Inc. Common to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Hemab Therapeutics Holdings, Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for Hemab Therapeutics Holdings, Inc. Common Stock. For the full company profile including market capitalisation, see COAG stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.17x | $-61.46 Million | $-61.48 Million | $371.42 Million | ▲ +22.7% |
| 2024 | -0.21x | $-45.31 Million | $-45.59 Million | $211.55 Million | — |